These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348 [TBL] [Abstract][Full Text] [Related]
9. A phase II trial using thalidomide for Langerhans cell histiocytosis. McClain KL; Kozinetz CA Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818 [TBL] [Abstract][Full Text] [Related]
10. Langerhans' cell histiocytosis of the temporal bone in children. Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926 [TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis in children less than 2 years of age. Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120 [TBL] [Abstract][Full Text] [Related]
12. Predictors of outcome in children with Langerhans cell histiocytosis. Jubran RF; Marachelian A; Dorey F; Malogolowkin M Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381 [TBL] [Abstract][Full Text] [Related]